BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38482376)

  • 1. Computing a cure for fragile-X syndrome.
    Mohamad T; Lepage JF
    Brain Commun; 2024; 6(2):fcae066. PubMed ID: 38482376
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental therapeutic models for fragile X syndrome].
    de Diego-Otero Y
    Rev Neurol; 2001 Oct; 33 Suppl 1():S70-6. PubMed ID: 12447824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA Can Be a Probable Mechanism and a Novel Target for Diagnosis and Therapy in Fragile X Syndrome.
    Huang G; Zhu H; Wu S; Cui M; Xu T
    Front Genet; 2019; 10():446. PubMed ID: 31191598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quest for fragile X biomarkers.
    Westmark CJ
    Mol Cell Pediatr; 2014 Dec; 1(1):1. PubMed ID: 26567095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FMR1 and the fragile X syndrome: human genome epidemiology review.
    Crawford DC; Acuña JM; Sherman SL
    Genet Med; 2001; 3(5):359-71. PubMed ID: 11545690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Throughput Screening to Identify Compounds That Increase Fragile X Mental Retardation Protein Expression in Neural Stem Cells Differentiated From Fragile X Syndrome Patient-Derived Induced Pluripotent Stem Cells.
    Kumari D; Swaroop M; Southall N; Huang W; Zheng W; Usdin K
    Stem Cells Transl Med; 2015 Jul; 4(7):800-8. PubMed ID: 25999519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Courting a cure for fragile X.
    Dölen G; Bear MF
    Neuron; 2005 Mar; 45(5):642-4. PubMed ID: 15748838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic variability to medication management: an update on fragile X syndrome.
    Elhawary NA; AlJahdali IA; Abumansour IS; Azher ZA; Falemban AH; Madani WM; Alosaimi W; Alghamdi G; Sindi IA
    Hum Genomics; 2023 Jul; 17(1):60. PubMed ID: 37420260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated transcriptome analysis of human iPS cells derived from a fragile X syndrome patient during neuronal differentiation.
    Lu P; Chen X; Feng Y; Zeng Q; Jiang C; Zhu X; Fan G; Xue Z
    Sci China Life Sci; 2016 Nov; 59(11):1093-1105. PubMed ID: 27730449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fragile X tremor ataxia syndrome (FXTAS): a new kind of spinocerebelar ataxia associated to fragile X syndrome premutation carriers].
    Milà M; Madrigal I; Kulisevsky J; Pagonabarraga J; Gómez B; Sánchez A; Rodríguez-Revenga L
    Med Clin (Barc); 2009 Jul; 133(7):252-4. PubMed ID: 19473671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klinefelter syndrome and associated fragile-X syndrome.
    Pueschel SM; O'Brien MM; Padre-Mendoza T
    J Ment Defic Res; 1987 Mar; 31 ( Pt 1)():73-9. PubMed ID: 3585988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic screening for fragile X syndrome in a cohort of 574 mentally retarded children.
    Gérard B; Le Heuzey MF; Brunie G; Lewine P; Saiag MC; Cacheux V; Da Silva F; Dugas M; Mouren-Simeoni MC; Elion J; Grandchamp B
    Ann Genet; 1997; 40(3):139-44. PubMed ID: 9401101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACOG Committee Opinion No. 469: Carrier screening for fragile X syndrome.
    Obstet Gynecol; 2010 Oct; 116(4):1008-1010. PubMed ID: 20859177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragile X Syndrome in children.
    Acero-Garcés DO; Saldarriaga W; Cabal-Herrera AM; Rojas CA; Hagerman RJ
    Colomb Med (Cali); 2023; 54(2):e4005089. PubMed ID: 37664646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal profiles of adaptive behavior in fragile X syndrome.
    Klaiman C; Quintin EM; Jo B; Lightbody AA; Hazlett HC; Piven J; Hall SS; Chromik LC; Reiss AL
    Pediatrics; 2014 Aug; 134(2):315-24. PubMed ID: 25070318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological, Psychiatric, and Multisystemic Involvement of Fragile X Syndrome Along With Its Pathophysiology, Methods of Screening, and Current Treatment Modalities.
    Ranjan R; Jha S; Prajjwal P; Chaudhary A; Dudeja P; Vora N; Mateen MA; Yousuf MA; Chaudhary B
    Cureus; 2023 Feb; 15(2):e35505. PubMed ID: 37007359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of population screening for fragile X syndrome.
    Hill MK; Archibald AD; Cohen J; Metcalfe SA
    Genet Med; 2010 Jul; 12(7):396-410. PubMed ID: 20548240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of the fragile X syndrome in Chinese mentally retarded populations is similar to that in Caucasians.
    Zhong N; Ju W; Xu W; Ye L; Shen Y; Wu G; Chen SH; Jin R; Hu XF; Yang A; Liu X; Poon P; Pang C; Zheng Y; Song L; Zhao P; Fu B; Gu H; Brown WT
    Am J Med Genet; 1999 May; 84(3):191-4. PubMed ID: 10331588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do individuals with fragile X syndrome show developmental stuttering or not? Comment on "Speech fluency in fragile X syndrome" by van Borsel, Dor and Rondal.
    Howell P
    Clin Linguist Phon; 2008 Feb; 22(2):163-7. PubMed ID: 18253874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA Methylation, Mechanisms of
    Nobile V; Pucci C; Chiurazzi P; Neri G; Tabolacci E
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33669384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.